BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $243,000 | -14.4% | 2,828 | -19.8% | 0.02% | -21.4% |
| Q3 2021 | $284,000 | -5.3% | 3,528 | -5.4% | 0.03% | -9.7% |
| Q2 2021 | $300,000 | -4.5% | 3,728 | 0.0% | 0.03% | -8.8% |
| Q1 2021 | $314,000 | +5.0% | 3,728 | 0.0% | 0.03% | -2.9% |
| Q4 2020 | $299,000 | -1.6% | 3,728 | -1.3% | 0.04% | -14.6% |
| Q3 2020 | $304,000 | -6.5% | 3,778 | 0.0% | 0.04% | -12.8% |
| Q2 2020 | $325,000 | -1.8% | 3,778 | -7.4% | 0.05% | -16.1% |
| Q1 2020 | $331,000 | -25.5% | 4,078 | -23.3% | 0.06% | +1.8% |
| Q4 2019 | $444,000 | -5.3% | 5,314 | -0.9% | 0.06% | -11.3% |
| Q3 2019 | $469,000 | -5.8% | 5,364 | -11.7% | 0.06% | -7.5% |
| Q2 2019 | $498,000 | +0.8% | 6,077 | 0.0% | 0.07% | -2.9% |
| Q1 2019 | $494,000 | +23.5% | 6,077 | 0.0% | 0.07% | +9.5% |
| Q4 2018 | $400,000 | -21.1% | 6,077 | -7.6% | 0.06% | -6.0% |
| Q3 2018 | $507,000 | +4.5% | 6,575 | 0.0% | 0.07% | +81.1% |
| Q2 2018 | $485,000 | +12.8% | 6,575 | -0.4% | 0.04% | -41.3% |
| Q1 2018 | $430,000 | -9.5% | 6,600 | -10.2% | 0.06% | -7.4% |
| Q4 2017 | $475,000 | -1.0% | 7,350 | -3.9% | 0.07% | -2.9% |
| Q3 2017 | $480,000 | -8.4% | 7,650 | -11.6% | 0.07% | -12.5% |
| Q2 2017 | $524,000 | +10.5% | 8,650 | -5.5% | 0.08% | +5.3% |
| Q1 2017 | $474,000 | +10.7% | 9,150 | -5.2% | 0.08% | +4.1% |
| Q4 2016 | $428,000 | -32.6% | 9,650 | -27.7% | 0.07% | -33.6% |
| Q3 2016 | $635,000 | +2.3% | 13,350 | -2.8% | 0.11% | -3.5% |
| Q2 2016 | $621,000 | +9.9% | 13,737 | -0.2% | 0.11% | -1.7% |
| Q1 2016 | $565,000 | -4.2% | 13,763 | -11.0% | 0.12% | -6.5% |
| Q4 2015 | $590,000 | +28.5% | 15,463 | +10.7% | 0.12% | +17.0% |
| Q3 2015 | $459,000 | -58.1% | 13,963 | -10.9% | 0.11% | -54.5% |
| Q2 2015 | $1,096,000 | +13.5% | 15,663 | +11.0% | 0.23% | +14.2% |
| Q1 2015 | $966,000 | -57.0% | 14,111 | -53.9% | 0.20% | -15.4% |
| Q4 2014 | $2,244,000 | +126.9% | 30,620 | +122.1% | 0.24% | +12.1% |
| Q3 2014 | $989,000 | -7.2% | 13,785 | -6.4% | 0.22% | -6.9% |
| Q2 2014 | $1,066,000 | +14.5% | 14,735 | +16.4% | 0.23% | +2.7% |
| Q1 2014 | $931,000 | +89.6% | 12,660 | +79.3% | 0.22% | +77.2% |
| Q4 2013 | $491,000 | – | 7,060 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |